MacroGenics, Inc. (MGNX) Social Stream
MACROGENICS INC (MGNX) Price Targets From Analysts
Use the tables below to see what analysts covering MACROGENICS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-04 | 9 | $50 | $17 | $37.5 | $10.2 | 267.65% |
2021-11-17 | 8 | $50 | $30 | $40.428 | $10.2 | 296.35% |
2022-02-07 | 9 | $50 | $30 | $40.375 | $10.2 | 295.83% |
2022-02-11 | 10 | $50 | $30 | $39.333 | $10.2 | 285.62% |
2022-02-24 | 10 | $50 | $23 | $35.444 | $10.2 | 247.49% |
2022-02-28 | 11 | $50 | $21 | $34 | $10.2 | 233.33% |
2022-05-03 | 10 | $50 | $21 | $32.777 | $10.2 | 221.34% |
2022-05-04 | 10 | $50 | $15 | $31.222 | $10.2 | 206.1% |
2022-07-18 | 9 | $50 | $4 | $22.333 | $10.2 | 118.95% |
2022-08-09 | 10 | $50 | $4 | $20.9 | $10.2 | 104.9% |
2022-08-23 | 11 | $50 | $4 | $19.9 | $10.2 | 95.1% |
2022-08-29 | 11 | $50 | $4 | $19.4 | $10.2 | 90.2% |
2022-09-12 | 11 | $50 | $4 | $16.9 | $10.2 | 65.69% |
2022-11-03 | 10 | $30 | $4 | $13.444 | $10.2 | 31.8% |
2022-11-07 | 10 | $30 | $4 | $13.666 | $10.2 | 33.98% |
2022-11-14 | 10 | $20 | $5 | $13.125 | $10.2 | 28.68% |
2022-11-23 | 9 | $20 | $5 | $12 | $10.2 | 17.65% |
2023-03-09 | 10 | $20 | $5 | $12.222 | $10.2 | 19.82% |
2023-03-15 | 10 | $20 | $5 | $12 | $10.2 | 17.65% |
2023-03-20 | 11 | $20 | $5 | $12.222 | $10.2 | 19.82% |
2023-05-09 | 10 | $17 | $5 | $11.444 | $10.2 | 12.2% |
2023-08-10 | 10 | $17 | $8 | $12.75 | $10.2 | 25% |
2023-11-06 | 10 | $17 | $7 | $12.333 | $10.2 | 20.91% |
2023-11-13 | 10 | $17 | $7 | $11.625 | $10.2 | 13.97% |
2023-12-20 | 11 | $17 | $10 | $12.428 | $10.2 | 21.84% |
The Trend in the Analyst Price Target
Over the past 33 months, MGNX's average price target has gone down $21.37.
MGNX reports an average of 78.93% for its upside potential over the past 41 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-03-21 | 11 | 20 | 5 | 12.300 | 7.12 | 72.75% |
2023-05-09 | 11 | 17 | 8 | 12.250 | 7.18 | 70.61% |
2023-05-09 | 11 | 17 | 5 | 11.444 | 7.18 | 59.39% |
2023-05-09 | 9 | 17 | 8 | 12.250 | 7.18 | 70.61% |
2023-05-10 | 9 | 17 | 8 | 12.750 | 7.21 | 76.84% |
MGNX Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.36 | 9 | 0 | 2 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
MGNX's average broker recommendation rating improved by 0.54 over the prior 26 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MGNX has a lower variance in analysts' estimates than -3243.98% of all US stocks.
- MGNX has a greater average analyst price target than 905.45% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, MACROGENICS INC's number of analysts covering the stock is greater than 2783.15% of them.
- MACROGENICS INC's upside potential (average analyst target price relative to current price) is higher than 1513.88% of Pharmaceutical Products stocks.
Stocks similar to MACROGENICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CYRX, INSM, and SAVA.
View All Top Stocks by Price Target
Make investment decisions regarding MGNX using the data that counts. Try POWR Ratings for free.